MAI Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80K | Buy |
5,177
+3,520
| +212% | +$54.4K | ﹤0.01% | 1517 |
|
|
2025
Q1 | $24.6K | Buy |
1,657
+60
| +4% | +$892 | ﹤0.01% | 1965 |
|
|
2024
Q4 | $21.1K | Buy |
+1,597
| New | +$21.1K | ﹤0.01% | 2059 |
|
|
2021
Q3 | – | Sell |
-19,135
| Closed | -$322K | – | 800 |
|
|
2021
Q2 | $322K | Sell |
19,135
-1,767
| -8% | -$29.7K | 0.01% | 564 |
|
|
2021
Q1 | $382K | Buy |
20,902
+591
| +3% | +$10.8K | 0.01% | 510 |
|
|
2020
Q4 | $370K | Sell |
20,311
-917
| -4% | -$16.7K | 0.01% | 481 |
|
|
2020
Q3 | $379K | Sell |
21,228
-371
| -2% | -$6.62K | 0.01% | 412 |
|
|
2020
Q2 | $387K | Sell |
21,599
-2,608
| -11% | -$46.7K | 0.01% | 399 |
|
|
2020
Q1 | $367K | Buy |
24,207
+688
| +3% | +$10.4K | 0.02% | 386 |
|
|
2019
Q4 | $464K | Buy |
+23,519
| New | +$464K | 0.02% | 389 |
|
|
2019
Q3 | – | Sell |
-11,974
| Closed | -$212K | – | 529 |
|
|
2019
Q2 | $212K | Sell |
11,974
-1,789
| -13% | -$31.7K | 0.01% | 470 |
|
|
2019
Q1 | $280K | Buy |
+13,763
| New | +$280K | 0.01% | 344 |
|